New Research Reports

Retail Research

End of Day Summary

Shree Cement’s (SRCM) FY26 playbook, as articulated by Chairman Mr H M Bangur in a recent media interview (Link), seems decisive and leaves little room for ambiguity.

Retail Research

PGHH’s strategic pillars that drive growth in the Personal and Healthcare categories are intact. The company holds a dominant ~50% market share in both the Feminine Hygiene and Healthcare categories.

Retail Research

We interacted with LTIMindtree’s management to understand the company’s business strategy and growth prospects. For Q1FY26, LTIMindtree expects strong order inflow to continue, bolstered by a landmark $450 million, seven-year deal, following robust order inflows of $1.68 billion in Q3FY25 and $1.6 billion in Q4FY25.

The company's overall performance was strong, driven by efficient execution in its renewable pipeline, full-scale solar cell and module operations, and sustained leadership in rooftop solar and EV infrastructure. Strategic initiatives such as pumped hydro development, clean energy expansion and digital grid modernisation underscore its commitment to long-term growth. Management's calibrated capital allocation, rural electrification push and third-party EPC order execution offer...

Asian Markets trade lower as investors assess U.S. President Donald Trump's trade deal with China. Nikkei, Shanghai, and Hang Seng are down 0.75%, 0.1%, and 0.74%, respectively.

We recommend a BUY rating on the stock with a TP of Rs 955/share, implying an upside of 10% from the CMP.

Distribution Diversified, Growth Amplified

IPO NOTE

Black & White

Black & White

Newsletter

Retail Research

End of Day Summary

We believe CIE's technological strengths will continue to support its valuation, similar to its listed MNC peers in the sector. However, due to weaker demand in Europe and the U.S., along with a slower-than-expected EV ramp-up, we are revising our PAT guidance downward, maintaining a cautious stance on margin estimates for near term. We expect the geopolitical shift in the supply chain realignment to benefit the domestic market in the long run, which is expected to factor in the price and the valuation looks reasonable at the given margin. CIE has...

The company unveiled its R&D product NRC-2694 for metastatic head and neck cancer, which is currently in phase 2. The management expects to gain more clarity after a year and a half. The company currently is doing patient recruitment...

V-Guard Industries Ltd (VGRD) is one of the leading players in the electrical consumer durables space. Major product segments include Stabilizers, Cables & Wires, UPS, Pumps and Electrical Appliances. In Q4FY25, revenue grew 15% YoY, exceeding estimates, driven by strong growth in Electronics (+26% YoY), Electricals (+15% YoY), and the Consumer division (+12% YoY). However, the Sunflames' business declined by 24% YoY. EBITDA grew by 12% YoY, while EBITDA margins declined by 22bps YoY to 9.3% despite a 120bps YoY improvement in gross margins, largely due to higher...